David Templeton
Chief Tech/Sci/R&D Officer bij N4 PHARMA PLC
Vermogen: - $ op 31-03-2024
Profiel
David Templeton is currently the Executive Director & Technical Director at N4 Pharma Plc since 2019.
Previously, he worked as the Director-Clinical Pharmacology at Eisai Ltd.
(United Kingdom) from 2007 to 2010 and as the Head-Non Clinical Development at Celltech Ltd.
from 2003 to 2004.
He also held the position of Head-Biometrics at Merck Generics Ltd.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
N4 PHARMA PLC
-.--% | 31-12-2022 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van David Templeton
Bedrijven | Functie | Begin |
---|---|---|
N4 PHARMA PLC | Chief Tech/Sci/R&D Officer | 21-05-2019 |
Eerdere bekende functies van David Templeton
Bedrijven | Functie | Einde |
---|---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Corporate Officer/Principal | 01-01-2010 |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | 01-01-2004 |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
N4 PHARMA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Health Technology |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Health Technology |